Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 1984 Mar;47(3):472–477. doi: 10.1128/aem.47.3.472-477.1984

Aflatoxin B1 dihydrodiol antibody: production and specificity.

J J Pestka, F S Chu
PMCID: PMC239704  PMID: 6546848

Abstract

A specific antibody for 2,3-dihydro-2,3-dihydroxyaflatoxin B1 (AFB1-diol) was prepared, and its reactivity was characterized for the major aflatoxin (AF) B1 (AFB1) metabolites. Reductive alkylation was used to conjugate AFB1-diol to ethylenediamine-modified bovine serum albumin (EDA-BSA) and horseradish peroxidase for use as an immunogen and an enzyme-linked immunosorbent assay (ELISA) marker, respectively. High reactant ratios, 1:5 and 1:10, for AFB1-diol-EDA-BSA (wt/wt) resulted in precipitated conjugates which were poorly immunogenic. However, a soluble conjugate obtained by using a 1:25 ratio of AFB1-diol to EDA-BSA could be used for obtaining high-titer AFB1-diol rabbit antibody within 10 weeks. Competitive ELISAs revealed that the AFB1-diol antibody detected as little as 1 pmol of AFB1-diol per assay. Cross-reactivity of AFB1-diol antibody in the competitive ELISA with AF analogs was as follows: AFB1-diol, 100%; AFB1, 200%; AFM1, 130%; AFB2a, 100%; AFG1, 6%; AFG2, 4%; aflatoxicol, 20%; AFQ1, 2%; AFB1-modified DNA, 32%; and 2,3-dihydro-2-(N7-guanyl)-3-hydroxy AFB1, 0.6%. These data indicated that the cyclopentanone and methoxy moieties of the AF molecule were the primary epitopes for the AFB1-diol antibody. The AFB1-diol competitive ELISA was subject to substantial interference by human, rat, and mouse serum albumins but not by BSA, Tris, human immunoglobulin G, or lysozyme. By using a noncompetitive, indirect ELISA with an AFB1-modified DNA solid phase, a modification level of one AFB1 residue for 200,000 nucleotides could be determined.

Full text

PDF
472

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashoor S. H., Chu F. S. Interaction of aflatoxin B2a with amino acids and proteins. Biochem Pharmacol. 1975 Oct 1;24(19):1799–1805. doi: 10.1016/0006-2952(75)90460-8. [DOI] [PubMed] [Google Scholar]
  2. Bassir O., Bababunmi E. A. The binding of aflatoxin B1 with serum albumin. Biochem Pharmacol. 1973 Jan 1;22(1):132–134. doi: 10.1016/0006-2952(73)90265-7. [DOI] [PubMed] [Google Scholar]
  3. Büchi G., Luk K., Müller P. M. Synthesis of aflatoxin Q1. J Org Chem. 1975 Nov 14;40(23):3458–3459. doi: 10.1021/jo00911a040. [DOI] [PubMed] [Google Scholar]
  4. Chu F. S. Chromatography of crude aflatoxins on adsorbosil-5. J Assoc Off Anal Chem. 1971 Nov;54(6):1304–1306. [PubMed] [Google Scholar]
  5. Chu F. S., Lau H. P., Fan T. S., Zhang G. S. Ethylenediamine modified bovine serum albumin as protein carrier in the production of antibody against mycotoxins. J Immunol Methods. 1982 Nov 26;55(1):73–78. doi: 10.1016/0022-1759(82)90078-3. [DOI] [PubMed] [Google Scholar]
  6. Essigmann J. M., Croy R. G., Nadzan A. M., Busby W. F., Jr, Reinhold V. N., Büchi G., Wogan G. N. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci U S A. 1977 May;74(5):1870–1874. doi: 10.1073/pnas.74.5.1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gaur P. K., Lau H. P., Pestka J. J., Chu F. S. Production and characterization of aflatoxin B2a antiserum. Appl Environ Microbiol. 1981 Feb;41(2):478–482. doi: 10.1128/aem.41.2.478-482.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Groopman J. D., Haugen A., Goodrich G. R., Wogan G. N., Harris C. C. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. Cancer Res. 1982 Aug;42(8):3120–3124. [PubMed] [Google Scholar]
  9. Haugen A., Groopman J. D., Hsu I. C., Goodrich G. R., Wogan G. N., Harris C. C. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4124–4127. doi: 10.1073/pnas.78.7.4124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hebert G. A., Pelham P. L., Pittman B. Determination of the optimal ammonium sulfate concentration for the fractionation of rabbit, sheep, horse, and goat antisera. Appl Microbiol. 1973 Jan;25(1):26–36. doi: 10.1128/am.25.1.26-36.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hertzog P. J., Smith J. R., Garner R. C. Characterisation of the imidazole ring-opened forms of trans-8,9-dihydro-8,9-dihydro-8-(7-guanyl)9-hydroxy aflatoxin B1. Carcinogenesis. 1982;3(6):723–725. doi: 10.1093/carcin/3.6.723. [DOI] [PubMed] [Google Scholar]
  12. Hertzog P. J., Smith J. R., Garner R. C. Production of monoclonal antibodies to guanine imidazole ring-opened aflatoxin B1DNA, the persistent DNA adduct in vivo. Carcinogenesis. 1982;3(7):825–828. doi: 10.1093/carcin/3.7.825. [DOI] [PubMed] [Google Scholar]
  13. Hsu I. C., Poirier M. C., Yuspa S. H., Grunberger D., Weinstein I. B., Yolken R. H., Harris C. C. Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res. 1981 Mar;41(3):1091–1095. [PubMed] [Google Scholar]
  14. Langone J. J., Van Vunakis H. Aflatoxin B; specific antibodies and their use in radioimmunoassay. J Natl Cancer Inst. 1976 Mar;56(3):591–595. doi: 10.1093/jnci/56.3.591. [DOI] [PubMed] [Google Scholar]
  15. Lin J. K., Kennan K. A., Miller E. C., Miller J. A. Reduced nicotinamide adenine dinucleotide phosphate-dependent formation of 2,3-dihydro-2,3-dihydroxyaflatoxin B1 from aflatoxin B1 by hepatic microsomes. Cancer Res. 1978 Aug;38(8):2424–2428. [PubMed] [Google Scholar]
  16. Lin J. K., Miller J. A., Miller E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 1977 Dec;37(12):4430–4438. [PubMed] [Google Scholar]
  17. Martin C. N., Garner R. C. Aflatoxin B -oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids. Nature. 1977 Jun 30;267(5614):863–865. doi: 10.1038/267863a0. [DOI] [PubMed] [Google Scholar]
  18. Neal G. E., Colley P. J. The formation of 2,3-dihydro-2,3-dihydroxy aflatoxin B1 by the metabolism of aflatoxin B1 in vitro by rat liver microsomes. FEBS Lett. 1979 May 15;101(2):382–386. doi: 10.1016/0014-5793(79)81049-2. [DOI] [PubMed] [Google Scholar]
  19. Neal G. E., Judah D. J., Stirpe F., Patterson D. S. The formation of 2,3-dihydroxy-2,3-dihydro-aflatoxin B1 by the metabolism of aflatoxin B1 by liver microsomes isolated from certain avian and mammalian species and the possible role of this metabolite in the acute toxicity of aflatoxin B1. Toxicol Appl Pharmacol. 1981 May;58(3):431–437. doi: 10.1016/0041-008x(81)90095-8. [DOI] [PubMed] [Google Scholar]
  20. Oellerich M. Enzyme immunoassays in clinical chemistry: present status and trends. J Clin Chem Clin Biochem. 1980 Apr;18(4):197–208. doi: 10.1515/cclm.1980.18.4.197. [DOI] [PubMed] [Google Scholar]
  21. Peers F. G., Linsell C. A. Dietary aflatoxins and liver cancer--a population based study in Kenya. Br J Cancer. 1973 Jun;27(6):473–484. doi: 10.1038/bjc.1973.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pestka J. J., Beery J. T., Chu F. S. Indirect immunoperoxidase localization of aflatoxin B1 in rat liver. Food Chem Toxicol. 1983 Feb;21(1):41–48. doi: 10.1016/0278-6915(83)90267-3. [DOI] [PubMed] [Google Scholar]
  23. Pestka J. J., Gaur P. K., Chu F. S. Quantitation of aflatoxin B1 and aflatoxin B1 antibody by an enzyme-linked immunosorbent microassay. Appl Environ Microbiol. 1980 Dec;40(6):1027–1031. doi: 10.1128/aem.40.6.1027-1031.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pestka J. J., Li Y. K., Chu F. S. Reactivity of aflatoxin B2a antibody with aflatoxin B1-modified DNA and related metabolites. Appl Environ Microbiol. 1982 Nov;44(5):1159–1165. doi: 10.1128/aem.44.5.1159-1165.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pestka J. J., Li Y., Harder W. O., Chu F. S. Comparison of radioimmunoassay and enzyme-linked immunosorbent assay for determining aflatoxin M1 in milk. J Assoc Off Anal Chem. 1981 Mar;64(2):294–301. [PubMed] [Google Scholar]
  26. Peters H., Dierich M. P., Dose K. Enzyme-linked immunosorbent assay for detection of T-2 toxin. Hoppe Seylers Z Physiol Chem. 1982 Dec;363(12):1437–1441. doi: 10.1515/bchm2.1982.363.2.1437. [DOI] [PubMed] [Google Scholar]
  27. Pier A. C., Richard J. L., Cysewski S. J. Implications of mycotoxins in animal disease. J Am Vet Med Assoc. 1980 Apr 15;176(8):719–724. [PubMed] [Google Scholar]
  28. Rao V. N., Valmikinathan K., Verghese N. Binding of aflatoxin by plasma albumin in vitro. Biochim Biophys Acta. 1968 Sep 3;165(2):288–289. doi: 10.1016/0304-4165(68)90058-5. [DOI] [PubMed] [Google Scholar]
  29. Scoppa P., Borlè W. O. Interazione dell'aflatossina B 1 con l'albumina: studio cromatografico mediante il metod dell'eluizione frontale. Boll Soc Ital Biol Sper. 1971 Apr 15;47(7):201–205. [PubMed] [Google Scholar]
  30. Scoppa P., Marafante E. Interazione dell'aflatossina B 1 con l'albumina: studio spettrofotometrico mediante esame degli spettri differenziali. Boll Soc Ital Biol Sper. 1971 Apr 15;47(7):198–201. [PubMed] [Google Scholar]
  31. Shank R. C., Bhamarapravati N., Gordon J. E., Wogan G. N. Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations of Thailand. Food Cosmet Toxicol. 1972 Apr;10(2):171–179. doi: 10.1016/s0015-6264(72)80195-0. [DOI] [PubMed] [Google Scholar]
  32. Stark A. A. Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action. Annu Rev Microbiol. 1980;34:235–262. doi: 10.1146/annurev.mi.34.100180.001315. [DOI] [PubMed] [Google Scholar]
  33. Swenson D. H., Miller J. A., Miller E. C. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1. Cancer Res. 1975 Dec;35(12):3811–3823. [PubMed] [Google Scholar]
  34. Wang T. V., Cerutti P. Spontaneous reactions of aflatoxin B1 modified deoxyribonucleic acid in vitro. Biochemistry. 1980 Apr 15;19(8):1692–1698. doi: 10.1021/bi00549a027. [DOI] [PubMed] [Google Scholar]
  35. Wei R. D., Lee S. S. Binding of aflatoxins B1 and G1 to human serum proteins. Experientia. 1971 Apr 15;27(4):458–460. doi: 10.1007/BF02137311. [DOI] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES